Roanoke Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,000
| Closed | -$463K | – | 95 |
|
|
2024
Q3 | $463K | Hold |
10,000
| – | – | 0.15% | 71 |
|
|
2024
Q2 | $325K | Hold |
10,000
| – | – | 0.11% | 74 |
|
|
2024
Q1 | $252K | Hold |
10,000
| – | – | 0.08% | 89 |
|
|
2023
Q4 | $325K | Hold |
10,000
| – | – | 0.12% | 80 |
|
|
2023
Q3 | $272K | Hold |
10,000
| – | – | 0.11% | 86 |
|
|
2023
Q2 | $222K | Hold |
10,000
| – | – | 0.09% | 96 |
|
|
2023
Q1 | $217K | Sell |
10,000
-5,000
| -33% | -$109K | 0.09% | 96 |
|
|
2022
Q4 | $305K | Hold |
15,000
| – | – | 0.14% | 90 |
|
|
2022
Q3 | $385K | Hold |
15,000
| – | – | 0.18% | 82 |
|
|
2022
Q2 | $357K | Sell |
15,000
-5,000
| -25% | -$119K | 0.16% | 84 |
|
|
2022
Q1 | $450K | Buy |
+20,000
| New | +$450K | 0.17% | 82 |
|